According to IMARC Group latest report titled” Legionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on legionella testing market report. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global legionella testing market size reached US$ 285.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 455.6 Million by 2028, exhibiting a growth rate (CAGR) of 8% during 2023-2028.
Legionella testing is a diagnostic process aimed at detecting the presence of Legionella bacteria in water sources. Legionella is a bacterium responsible for causing Legionnaires' disease, a severe form of pneumonia, and Pontiac fever, a milder flu-like illness. Water systems, particularly in buildings with complex plumbing or cooling systems, can be potential breeding grounds for Legionella. Testing involves collecting water samples from various points within a facility, such as taps, showers, or cooling towers. These samples are then analyzed to determine the concentration of Legionella bacteria. Regular Legionella testing is crucial for preventing outbreaks, ensuring the safety of water supplies, and maintaining compliance with health and safety regulations in environments where individuals may be exposed to contaminated water droplets.
Get a Sample Copy of this Report: https://www.imarcgroup.com/legionella-testing-market/requestsample
Market Trends:
The global market is majorly driven by the increasing awareness of Legionnaires' disease and its potential outbreaks. In line with this, the rising testing initiatives, especially in high-risk environments like healthcare facilities, hotels, and large commercial buildings with complex water systems, are positively influencing the market. Furthermore, the regulatory frameworks and guidelines mandating Legionella testing in certain industries and geographical regions contribute significantly to market growth, compelling organizations to implement regular testing in their water safety management plans. Besides, the COVID-19 pandemic has further emphasized the importance of indoor air quality, prompting heightened attention to Legionella testing as part of comprehensive building safety measures. Technological advancements in testing methodologies, including rapid and accurate diagnostic techniques, enhance the efficiency and reliability of Legionella testing services, further propelling market expansion. Moreover, the growing emphasis on preventive healthcare and the increasing collaboration between public health agencies, water management professionals, and testing service providers contribute to a proactive approach to Legionella control, fostering market development. Additionally, the incorporation of cloud-based platforms for data management and real-time monitoring in Legionella testing services aligns with the broader trend of digitization in healthcare and environmental monitoring. As the global community recognizes the importance of early detection and mitigation of Legionella risks, the market for Legionella testing is poised for sustained growth, ensuring safer water supplies and minimizing the potential for Legionnaires' disease outbreaks.
View Full Report with TOC List of Figure: https://www.imarcgroup.com/legionella-testing-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Becton
- Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc
- Eiken Chemical Co. Ltd
- Quidel Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc
Legionella Testing Market Segmentation:
Our report has categorized the market based on region, application and end use industry.
Breakup by Application:
- Water Testing
- Microbial Culture
- DFA Stain
- PCR
- Others
- IVD Testing
- Blood Culture
- Urine Antigen Test
- DFA Stain
- PCR
- Others
Breakup by End User:
- Hospitals and Clinics
- Diagnostic Laboratory
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
